Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ARNA | PCVX | APLS | ||
Company | Arena Pharmaceuticals | Vaxcyte Inc | Apellis Pharmaceuticals Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 99.97 | 61.05 | 48.84 | ||
High | 100.00 | 61.98 | 50.40 | ||
Low | 99.97 | 59.97 | 48.62 | ||
Last | 99.99 | 60.30 | 49.93 | ||
Change | +0.06 | -0.58 | +1.21 | ||
% Change | +0.06% | -0.95% | +2.48% | ||
Volume | 5,718,500 | 701,700 | 1,245,700 | ||
20-Day Average Volume | 1,676,465 | 674,760 | 1,204,865 | ||
Previous Close | 99.93 | 60.88 | 48.72 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 94.81 | 63.48 | 53.38 | ||
20-Day Raw Stochastic | 99.86% | 8.84% | 26.13% | ||
20-Day Relative Strength | 75.07% | 38.29% | 39.06% | ||
Weighted Alpha | -14.40 | +31.87 | -7.89 | ||
Today's Opinion | 100% Buy | 8% Buy | 40% Sell | ||
Previous Opinion | 100% Buy | 8% Buy | 40% Sell | ||
Last Month's Opinion | 100% Buy | 56% Buy | 24% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +6.34% since 03/03/22 | -3.41% since 04/17/24 | +3.96% since 04/17/24 | ||
Low | 93.54 on 03/07/22 | 59.39 on 04/19/24 | 46.40 on 04/18/24 | ||
High | 100.00 on 03/10/22 | 63.22 on 04/22/24 | 50.40 on 04/24/24 | ||
1-Month | |||||
%Chg | +6.37% since 02/10/22 | -10.31% since 03/22/24 | -9.86% since 03/22/24 | ||
Low | 92.85 on 02/22/22 | 59.39 on 04/19/24 | 46.40 on 04/18/24 | ||
High | 100.00 on 03/10/22 | 69.68 on 03/28/24 | 59.91 on 04/01/24 | ||
3-Month | |||||
%Chg | +100.22% since 12/10/21 | -4.62% since 01/24/24 | -24.94% since 01/24/24 | ||
Low | 89.03 on 01/25/22 | 59.39 on 04/19/24 | 46.40 on 04/18/24 | ||
High | 100.00 on 03/10/22 | 82.04 on 02/28/24 | 71.90 on 02/26/24 | ||
6-Month | |||||
%Chg | +68.36% since 09/10/21 | +25.29% since 10/24/23 | +1.98% since 10/24/23 | ||
Low | 48.12 on 12/06/21 | 45.61 on 10/26/23 | 41.19 on 11/06/23 | ||
High | 100.00 on 03/10/22 | 82.04 on 02/28/24 | 73.80 on 01/09/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 6,165,283 | 6,621,248 | 5,874,755 | ||
Shares Outstanding, K | 61,659 | 108,759 | 120,582 | ||
Annual Sales | 50,000 | 0 | 396,590,000 | ||
Annual Net Income | -616,430,000 | -402,270,000 | -528,630,000 | ||
Last Quarter Sales | 50,000 | 0 | 146,380,000 | ||
Last Quarter Net Income | -155,610,000 | -180,800,000 | -88,580,000 | ||
60-Month Beta | 0.55 | 0.89 | 0.88 | ||
Per-Share Information | |||||
Most Recent Earnings | -2.54 on 02/23/22 | -1.82 on 02/27/24 | -0.73 on 02/27/24 | ||
Latest Earnings Date | 05/04/22 | 05/13/24 | 05/02/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |